Statistics for Vaxcyte, (id:7431 PCVX)

Valuation metrics

Market cap

12.90B

Enterprise value

10.23B

Trailing P/E (ttm)

-21.39

Forward P/E

-21.10

PEG ratio

-21.10

Price/Sales (ttm)

Price/Book (mrq)

3.62

Enterprise Value/Revenue

Enterprise Value/EBITDA

-17.08

Overview

Shares outstanding

124.64M

Float

115.47M

Shares short

9.34M

% Held by insiders

0.01%

% Held by institutions

1.02%

Average volume (10 days)

1.08M

Average volume (90 days)

Price summary

52-Week low

48.35

52-Week high

121.06

52-Week change

43.38%

Beta

1.01

50-Day moving average

112.01

200-Day moving average

82.42

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-14.94%

Return on equity

-21.06%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-599,025,984.00

Net income to common (ttm)

-507,648,000.00

Diluted EPS (ttm)

-4.42

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

2.18B

Total cash per share (mrq)

17.50

Total debt (mrq)

27.96M

Total Debt/Equity (mrq)

0.82

Current ratio (mrq)

1.79K%

Book value per share (mrq)

27.47

Cash flow

Cash flow statement

-470,036,000.00

Levered free cash flow (LFCF)

-404,953,120.00